Extra anatomical cryopreserved homograft solution for recurrent femoropopliteal bypass infection

Bibliographic Details
Title: Extra anatomical cryopreserved homograft solution for recurrent femoropopliteal bypass infection
Authors: Alberto M Settembrini, Leonardo Foresti, Giuseppe Cannizzo, Silvia Romagnoli, Daniele Bissacco, Santi Trimarchi
Source: Annals of Vascular Surgery - Brief Reports and Innovations, Vol 4, Iss 2, Pp 100292- (2024)
Publisher Information: Elsevier, 2024.
Publication Year: 2024
Collection: LCC:Diseases of the circulatory (Cardiovascular) system
LCC:Surgery
Subject Terms: Vascular graft infection, Peripheral bypass, Extra-anatomic bypass, Homograft, Vascular graft excision, Diseases of the circulatory (Cardiovascular) system, RC666-701, Surgery, RD1-811
More Details: Introduction Vascular graft infections (VGIs) are challenging and potentially life-threatening complications following femoropopliteal bypasses. The treatments of choice in peripheral VGIs are antimicrobial therapy, surgical excision, and in-situ reconstruction with an autologous superficial vein. An extraanatomical homograft bypass and antimicrobial therapy could be resolutive in patients presenting with recurrent VGIs and unavailable autologous veins.Case Report We present the case of a 74-year-old Caucasian man with a history of a below-the-knee (BTK) right femoropopliteal bypass using polytetrafluoroethylene (PTFE) for chronic peripheral artery disease (Rutherford Grade 3). He presented at the emergency department with septic arthritis of the right knee involving the previous PTFE femoropopliteal bypass. The graft was excised, and an insitu saphenous vein BTK femoropopliteal bypass was performed. Due to multiple recurrences of graft infection of the proximal anastomosis, an extra-anatomical cryopreserved arterial homograft reconstruction from the external iliac artery to the profunda femoral artery was necessary as a definitive treatment. At three years follow-up the patient is alive, with patency of both vascular reconstructions.Conclusion Despite aggressive treatment, managing vascular graft infections can be challenging, typically requiring a blend of surgical and medical interventions. Patient-specific surgical approaches, such as graft removal, infected tissue debridement andextra-anatomical reconstruction with biological grafts is crucial. In those patients with unavailable autologous veins, consideration could be given to a cryopreserved homograft due to its resistance against infections.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2772-6878
Relation: http://www.sciencedirect.com/science/article/pii/S2772687824000448; https://doaj.org/toc/2772-6878
DOI: 10.1016/j.avsurg.2024.100292
Access URL: https://doaj.org/article/f457cdce23024ef0bfbf22bb1a6dccf9
Accession Number: edsdoj.f457cdce23024ef0bfbf22bb1a6dccf9
Database: Directory of Open Access Journals
More Details
ISSN:27726878
DOI:10.1016/j.avsurg.2024.100292
Published in:Annals of Vascular Surgery - Brief Reports and Innovations
Language:English